GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » Interest Income

Chengda Pharmaceuticals Co (SZSE:301201) Interest Income : ¥1.7 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Chengda Pharmaceuticals Co's interest income for the three months ended in Mar. 2025 was ¥0.5 Mil. Its interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.7 Mil.


Chengda Pharmaceuticals Co Interest Income Historical Data

The historical data trend for Chengda Pharmaceuticals Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengda Pharmaceuticals Co Interest Income Chart

Chengda Pharmaceuticals Co Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.26 0.99 6.37 2.03

Chengda Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.44 0.46 0.36 0.49

Chengda Pharmaceuticals Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengda Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100
Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co Headlines

No Headlines